SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-013532
Filing Date
2023-05-22
Accepted
2023-05-22 15:44:43
Documents
1
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4156
  Complete submission text file 0000899243-23-013532.txt   6312
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TPB 2012 LLC 12412 POWERSCOURT DR SUITE 35 SAINT LOUIS MO 63131
Business Address
Donovan James Joseph III (Reporting) CIK: 0001978397 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 23944245

Mailing Address 12412 POWERSCOURT DRIVE SUITE 35 SAINT LOUIS MO 63131
Business Address 12412 POWERSCOURT DRIVE SUITE 35 SAINT LOUIS MO 63131 3143942104
TPB 2012 LLC (Reporting) CIK: 0001978542 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 23944246